Elon Musk's rocket maker SpaceX has acquired artificial intelligence startup xAI in a deal that will value the company at $1.25 trillion, CNBC has confirmed. The transaction comes ahead of a potential ...

X is putting its money where its mouth is. The Elon Musk-owned social media platform just pledged it will give $1 million to the user who creates the most popular long-form post using its newly ...

Netflix has confirmed plans ramp up AI use at the company, with plans to expand its tools for subtitle localization and advertisement creation for its subscribers in 2026. The streaming giant touched ...

Once exclusively a treatment for diabetes, GLP-1 medications have gone mainstream — forcing restaurants to adjust to changing appetites and nutrition needs. As GLP-1 medications normalize smaller ...

President Trump announced Saturday that he will implement a 10 percent tariff on Denmark and its European allies starting next month, ratcheting up the pressure in his bid to acquire Greenland. “We ...

Long-term GLP-1 use slows medical cost growth, according to findings published Jan. 13 from professional services firm Aon. The firm analyzed 192,000 GLP-1 users from July 2022 to March 2025, ...

Just when you thought the circular deals couldn’t get any more circular, OpenAI has invested in CEO Sam Altman’s brain computer interface (BCI) startup Merge Labs. Merge Labs, which defines itself as ...

On Thursday, OpenAI announced its investment in neurotech startup Merge Labs, cofounded by its CEO, billionaire Sam Altman. OpenAI will collaborate with the new venture to develop technology to link ...

ABUJA, Dec 30 (Reuters) - Nigeria will enforce sweeping new tax laws from January 1, President Bola Tinubu said on Tuesday, dismissing criticism over discrepancies between the gazetted text and the ...

Almost half of U.S. workers now report using artificial intelligence tools at work at least a few times per year, which steadily increased throughout 2025, according to a Dec. 14 report from Gallup.

(RTTNews) - Clearmind Medicine Inc. (CMND), a clinical-stage biotech company developing psychedelic-derived therapeutics, has announced a reverse share split of its issued and outstanding common ...

Grounded in emerging science, Danone’s research and innovation team is developing nutrient-dense products tailored to every stage of the GLP-1 user journey – and meeting the needs of the broader ...